Full Text View
Tabular View
No Study Results Posted
Related Studies
Reducing Snack Variety in Weight Loss Treatment
This study is ongoing, but not recruiting participants.
Study NCT00328744   Information provided by The Miriam Hospital
First Received: May 19, 2006   Last Updated: January 14, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

May 19, 2006
January 14, 2009
July 2006
Weight loss [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  • Weight loss
  • Dietary Intake
  • Change in hedonics of food
Complete list of historical versions of study NCT00328744 on ClinicalTrials.gov Archive Site
  • Diet [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  • Hedonics of food [ Time Frame: 18 months ] [ Designated as safety issue: No ]
Same as current
 
Reducing Snack Variety in Weight Loss Treatment
Reducing Snack Food Variety During Obesity Treatment

The rising prevalence of obesity in the United States is believed to be due to increased exposure to adverse environmental factors, such as food portion sizes and increased dietary variety. Although decreasing portion sizes is a strategy used in weight loss programs, research has not studied the effects of decreasing dietary variety. Cross-sectional studies show a positive association between variety and body weight and in our own studies the investigators have shown that greater reductions in the number of different snack foods (i.e., cookies, chips) consumed predicted greater decreases in overall caloric and fat intake and greater weight loss. Limiting variety may reduce intake through long-term sensory-specific satiety and/or monotony.

Reducing dietary variety is a novel dietary approach with the potential to improve long-term weight loss, which has not been studied as a clinical strategy in obesity research. The objective of this application is to conduct a randomized controlled trial of a behavioral weight loss intervention limiting the number of different snack foods consumed. Two hundred overweight and obese participants will be randomized to a standard behavioral intervention (Standard) or to a standard behavioral intervention that also limits the number of different snack foods consumed (Limited Variety). Both conditions will receive an 18-month standard behavioral intervention, using behavioral techniques (i.e., self-monitoring) to change eating behaviors.

Participants in the Limited Variety condition will also limit variety in snack foods to only two chosen snack foods throughout the intervention.

Measures of weight, snack food consumption and hedonics, and diet satisfaction will be taken at 0, 6, 12, and 18 months. This investigation will determine:

  1. if the Limited Variety condition produces greater weight loss than the Standard condition at 18 months;
  2. if the Limited Variety condition consumes fewer servings and calories from snack foods than the Standard condition;
  3. if limiting snack food variety produces long-term sensory-specific satiety and/or monotony.

Relevance: Experimental studies show that limiting dietary variety profoundly reduces intake. To date, there is no dietary prescription that has been tested that capitalizes on the effect of variety on intake that can be maintained. This will be the first investigation to examine methods of manipulating dietary variety that can be adhered to over time and that influence intake, weight loss, and weight loss maintenance.

 
 
Interventional
Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Obesity
  • Behavioral: Standard
  • Behavioral: Limited Variety
  • Experimental: Behavioral: Behavioral weight loss (Standard)
  • Experimental: Behavioral: Behavioral weight loss (Limited Variety)
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
200
March 2011
 

Inclusion Criteria:

  1. Age between 21 and 65 years. Older adults may have more medical co-morbidities, requiring greater medical supervision. Although pediatric obesity is a significant concern, this group has different nutritional needs and requires different levels of therapist and parental involvement than are proposed.
  2. Body mass index (BMI) between 27 and 45 kg/m2. Based upon the Evidence Report (72), weight loss is recommended for individuals with a BMI > 25.

A BMI of > 27 was chosen as eligibility criteria for this investigation because this level of BMI will allow for a 10% weight loss to occur prior to reaching a BMI of < 25. Individuals with a BMI of > 45 have more medical co-morbidities and require greater medical supervision, and thus will be considered ineligible for this investigation.

Exclusion Criteria:

  1. Report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q) (73). Individuals endorsing joint problems, prescription medication usage, or other medical conditions that could limit exercise will be required to obtain written physician consent to participate.
  2. Have an allergy to a food commonly found in snack foods (i.e., nuts, milk and egg proteins).
  3. Report major psychiatric diseases or organic brain syndromes.
  4. Are currently participating in a weight loss program and/or taking weight loss medication or lost > 5% of body weight during the past 6 months.
  5. Intend to move outside of the metropolitan area within the time frame of the investigation.
  6. Are pregnant, lactating, less than 6 months post-partum, or plan to become pregnant during the time frame of the investigation.
  7. Consume < 5 different types of snack food per week. Pilot data indicated that upon screening 44 participants, mean weekly variety of snack foods was 8.7 (range 2 to 14, with only two participants consuming < 5 snack foods per week).
Both
21 Years to 65 Years
Yes
 
United States
 
 
NCT00328744
Hollie Raynor, Ph.D., R.D., University of Tennessee
 
The Miriam Hospital
National Institutes of Health (NIH)
Principal Investigator: Hollie Raynor, PhD University of Tennessee
The Miriam Hospital
October 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.